Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

impe0096pl2 | Access to medicines | IMPE2023

It’s not "all too hard"! Together we CAN improve access to essential paediatric endocrine medicines for all. A roadmap to 2030.

Armstrong Kate

The inequitable and preventable morbidity and mortality experienced by children and young people living with endocrine conditions and other non-communicable diseases (NCDs) of childhood in resource poor settings is well recognised. Indeed, Member States acknowledged at the 66th World Health Assembly in 2013 that "Children can die from treatable non-communicable diseases, such as rheumatic heart disease, type 1 diabetes, asthma, and leukaemia, if health prom...

impe0096pl5 | The gut microbiome and novel approaches to childhood obesity | IMPE2023

Is microbiome treatment for obesity and metabolic syndrome a possibility?

Cutfield Wayne

We are in the midst of an obesity epidemic with one in three NZ preschool children overweight/obese. We have looked at whether microbiome treatment could ameliorate child obesity in those born by (i) Cesarean section (CS) and (ii) obese teenagers. (i) Association studies have shown a 30% increased risk of childhood obesity in those born by CS. A lack of exposure to maternal vaginal bacteria with CS disrupting the normal population of the early infant gut microbiome has been pr...